Middle East and Africa Alpha Emitters Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Alpha emitters are a type of radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide has been considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumour cell killing actions causing less damage to surrounding healthy tissues than beta-emitters, and this potential has caught market attention.

The Middle East & Africa Alpha Emitters Market Segments Size & Growth:

The Middle East & Africa Alpha emitters market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include the Ready availability of radiopharmaceuticals, Increased awareness about the potential benefits of targeted alpha therapy and Increasing incidences of cardiac & cancer ailments. However, Reimbursement issues, Stringent regulatory framework, Need for high capital investment and Shorter half-life of radiopharmaceuticals are thereby hampering the market growth.

The Middle East & Africa Alpha Emitters Market Segments Share:

The Middle East & Africa Alpha emitters market is categorised into Type of Radionuclide which comprises of Bismuth, Lead, Radium, Actinium, Bismuth, Astatine, Terbium and so on. By Medical Application, the market is segmented into Endocrine Tumors, Lymphoma, Bone Metastasis, Thyroid, Ovarian Cancer, Pancreatic Cancer, Melanoma, Glioma and so on. By Geography, Africa is projected to dominate the market with the most significant share and the growth in the Middle East & Africa economies is mainly attributed because of huge profit margins and growth prospects.

The Middle East & Africa Alpha Emitters Market Trends:

• Nordion, Bruce Power, and Cameco announced that they are going to work together to provide a reliable supply of Cobalt-60.
• The University of Missouri Research Reactor and its partners Nordion, a business of Sterigenics International, and General Atomics (GA), announced that MURR’s License Amendment Request (LAR) had been submitted to the U.S. Nuclear Regulatory Commission (NRC). This marks a critical step towards implementing domestic U.S. production of molybdenum-99 (Mo-99). Once operational, the output from this facility will be capable of supporting nearly half of U.S. demand for Mo-99, which currently must be imported from outside North America.

The Middle East & Africa Alpha Emitters Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

• Nordion, Inc.
• Cardinal Health, Inc.
• AlphaTau
• Lantheus Medical Imaging
• NTP Radioisotopes